Norges Bank
BIOA

Norges Bank’s BioAge Labs BIOA Stock Holding History

Norges Bank’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,829
Closed -$161K – 1866
2024
Q4 		$161K Sell
27,829
-12,171
-30% -$210K ﹤0.01% 1836
2024
Q3 		$832K Buy
+40,000
New +$801K ﹤0.01% 1748

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return

Norges Bank's BIOA Position: Q1 2025 in Review

Norges Bank sold out of BioAge Labs (BIOA) in Q1 2025, closing a stake of 27,829 shares — an estimated $161K sold.

Norges Bank first reported a position in BIOA in Q3 2024 and held it in 2 quarters. The position peaked at $832K in Q3 2024. 67 funds tracked by Wall St. Rank hold BIOA as of Q1 2025.

  • Norges Bank reported no remaining BioAge Labs position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 27,829 BioAge Labs shares in Q1 2025, an estimated $161K.
  • Norges Bank first reported a position in BioAge Labs in Q3 2024 and held it in 2 quarters.
  • Norges Bank's BioAge Labs position peaked at $832K in Q3 2024.
  • 67 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.